Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neurological Disorder Linked to Genetic Mutations

By LabMedica International staff writers
Posted on 04 Jan 2012
A gene has been detected that is linked to epilepsy in babies and movement disorders in older children. More...


The gene has been associated with the rare childhood neurological disorder known as paroxysmal kinesigenic dyskinesia with infantile convulsions or PKD/IC.

A large international team led by scientists at the University of California, San Francisco (UCSF; USA) studied ways that could help to improve the diagnosis of PKD/IC and may also help to explain other movement disorders, such as Parkinson's disease. The team has identified a perplexing gene in the brain called proline-rich transmembrane protein 2 (PRRT2). No knowledge exists about the function or ability of this gene, which bears little resemblance to anything else in the human genome.

The scientists conducted the study on a cohort of 103 families, which included one or more members with the PKD/IC manifestation. The investigators identified mutations in the PRRT2 gene that is present in the brain and spinal cord, during genetic testing of the families. The mutation causes the proteins that the PRRT2 gene encodes to shorten or to completely disappear from the individual's brain and spinal cord. According to the investigative team, the neurological symptoms may be caused due to a loss of neuronal regulation, meaning that when the genetic mutations cause the gene products to disappear, the nerve cells, which normally appear in those locations, may become overly excited, firing signals too frequently or strongly, which leads to the involuntary movements.

Louis Ptacek, MD, the senior author of the study, said, "This is both exciting and a little bit scary. Understanding the underlying biology of this disease is absolutely going to help us understand movement disorders in general." PKD/IC is a rare disorder in infants with epileptic seizures, affecting approximately one in every 100,000 children in the US, according to Prof. Ptacek's estimation. It commonly disappears within a year or two but often reemerges later in childhood as a movement disorder, which is characterized by sudden, startling, involuntary jerks when the children start moving. In some children just the thought of moving will cause them to jerk involuntarily. The disease is classified as idiopathic, which, is basically just another way of saying the cause is unknown. The study was published in the January 2012 issue of Cell Reports.

UCSF


Related Links:

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.